Key result
A hybrid endovascular approach (CERAB) resulted in a successful outcome for 1 patient with complex aortoiliac occlusive disease during the COVID-19 crisis.
Why the study?
The COVID-19 pandemic disrupted acute vascular surgery, prompting consideration of endovascular therapy to reduce perioperative risk and critical care utilization.
Case Report (n=1)
Hybrid endovascular reconstruction of the aortic bifurcation (CERAB) is a feasible alternative to aortobifemoral bypass that may reduce ICU utilization during the COVID-19 pandemic.
Answers are grounded in this paper and cite their sources.
Endovascular strategies may ease perioperative and ICU burdens in pandemic vascular care; single case leaves open need for prospective data.
The COVID-19 pandemic is disrupting the provision of acute vascular surgery across the globe. Limited evidence of the impact of nosocomial infection on patient outcomes as well as concerns about critical care capacity will likely have an impact on surgical decision-making. Endovascular therapy offers a way by which perioperative risk can be reduced for vascular patients while also reducing the impact of acute surgery on intensive care unit capacity. This case report describes the management of a patient with complex aortoiliac occlusive disease by a hybrid endovascular approach in light of these constraints, with a successful outcome.
No takes yet. Share an insight, caveat, or question.
McElligott et al. (2020) conducted a case report in complex aortoiliac occlusive disease (n=1). Hybrid covered endovascular reconstruction of the aortic bifurcation (CERAB) vs. aortobifemoral bypass was evaluated on successful outcome. A hybrid endovascular approach (CERAB) resulted in a successful outcome for 1 patient with complex aortoiliac occlusive disease during the COVID-19 crisis.
Synapse has enriched 10 related papers. Consider them for comparative context: